chinese glp 1 China patent expiry and new GLP‑1 entries intensify global obesity drug fight As China's drug industry races

Inflammation is what lights the match

The clinical progression of bremelanotide focused exclusively on specific sexual dysfunction endpoints under rigorous oversight, leaving unapproved variants outside the scope of standardized human efficacy trials

The Journal of Clinical Endocrinology & Metabolism, 92 (8), 28852892.

Our model simulations are reflective of the hepatic GSH environment, agreeing with the supra-pharmacological concentrations of doxorubicin required to illicit comparable GSH depletion in the liver 39

Glucose, as an osmotically active molecule, may reduce osmotic pressure by bringing water from the interstitium to the vessels, triggering retinal edema